Multisystem Organ Failure Following LipoDissolve Injections
- *Corresponding Author:
- Brandon Libby
Department of Emergency Medicine
Boston University/Boston Medical Center, USA
E-mail: [email protected]
Received date: September 04, 2013; Accepted date: October 15, 2013; Published date: October 20, 2013
Citation: Libby B, Ruha AM, Raschke R, Wong M (2013) Multisystem Organ Failure Following LipoDissolve Injections. J Clin Toxicol 3:171. doi: 10.4172/2161-0495.1000171
Copyright: © 2013 Libby B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
LipoDissolve, also known as injection lipolysis, is a procedure marketed as a means to rid the body of unwanted pockets of fat. Despite warnings by the Food and Drug Administration that the products used in this procedure have not been shown to be safe or effective and are not approved for this use, LipoDissolve continues to be used by beauty spas across the United States. The authors report a case of a 63-year-old woman who developed acute liver injury, acute renal failure necessitating hemodialysis, and pancreatitis soon after undergoing her first LipoDissolve therapy at a home spa.